Novartis AG vs First Trust NASDAQ Clean Edge Green Energy Idx Fd — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while First Trust NASDAQ Clean Edge Green Energy Idx Fd trades at $52.98. The key difference: Novartis AG pays a 3.17% dividend while First Trust NASDAQ Clean Edge Green Energy Idx Fd pays none, and Novartis AG is trading nearer its 52-week high, First Trust NASDAQ Clean Edge Green Energy Idx Fd nearer its low. Which is the better fit depends on your goals.
| NVS | QCLN | |
|---|---|---|
Market Cap | $290.25B | — |
Sector | Health | Sector/Thematic |
52-Week High | $168.62 | $68.47 |
52-Week Low | $113.50 | $34.31 |
Enterprise Value | $330.27B | — |
Dividend Yield | 3.17% | — |
Trailing returns across standard periods
Latest headlines on both assets
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →QCLN invests in U.S.-listed companies engaged in clean energy technologies. It focuses on solar power, wind, electric vehicles, and energy storage, with major holdings in firms like Tesla, ON Semiconductor, and Rivian.
Read more on QCLN →